President Donald Trump’s Day One executive order rescinding Biden-era Medicare and Medicaid price innovation programs signals sweeping changes to the drug and treatment pricing agency within the Centers for Medicare and Medicaid Services and perhaps a substantive shake-up in two of the largest federal social welfare programs.

On Capitol Hill, one of President Trump’s most consequential and controversial nominees made his case for the top job at the Department of Health and Human Services. In his first of two hearings, former environmental lawyer and presidential candidate Robert F.

RFK Jr.'s second Senate confirmation hearing focused on vaccines, Medicare, diversity, and science. Key Republicans were reticent to show support.

Senators grilled Robert F. Kennedy Jr. on if and how he would reform Medicaid and Medicare during his first confirmation hearing to become the next secretary of Health and Human Services.

Therefore, current Medicare and Medicaid enrollees will not see their drug prices ... had Medicare pay less for drugs that receive accelerated approvals from the Food and Drug Administration (FDA). The FDA grants accelerated approvals to promising drugs ...

Of the scores of day-one executive orders (EOs) issued by President Trump, the order rescinding a Biden administration executive order on

RFK Jr has long expressed views that conflict with scientific evidence, especially on vaccines, and his nomination has provoked opposition from public health experts. But he has also adopted positions with popular support, scrutinising the use of food additives and urging that the power of big pharma be curbed.

Over rigorous questioning from senators Wednesday, Robert F. Kennedy Jr. laid out his vision to lead the Department Health and Human Services, while backtracking on his past statements in support of abortion and against vaccines.

Kennedy will also have to win over the swing votes of Sens. Susan Collins, Lisa Murkowski and Mitch McConnell, who have raised concerns about Kennedy and also voted against Trump’s defense secretary nominee.

A key Republican senator on Thursday said he was struggling with Robert F. Kennedy Jr's nomination by President Donald Trump to run the top U.S. health agency, saying he had reservations about the nominee's "misleading arguments" on vaccines.

Kennedy Jr, President Donald Trump's pick to run the top U.S. health agency, argued on Thursday that his controversial views on vaccines were misrepresented in a charged Senate Health committee hearing,

The HHS Secretary nominee confused Medicare and Medicaid programs, though he would be responsible for them if confirmed. We break down the difference.